Bioconjugate Chemistry · 2001 · 164 citations · 13 references
PharmacyBiotechnologyPharmaceuticsDrug DeliveryGene DeliveryGene ExpressionGene Delivery SystemsGene Delivery VectorsIn Vivo Gene DeliveryNucleic Acid DeliveryPlasmid Dna DeliveryPolymeric Gene CarriersEndosomal Escape DesignGene Delivery CarriersIn Vivo DeliveryIntracellular Delivery Of Nucleic AcidsNonviral VectorsNucleic Acid Delivery SystemsPh-sensitive PolymersTransfection Efficiency
The efficient release of nonviral gene carriers from endosomes is crucial for successful DNA delivery into the cell nucleus. The study aimed to determine whether PPAA could enhance transfection efficiencies by promoting endosomal escape of nonviral vectors. A synthetic pH‑sensitive anionic polymer, PPAA, was designed to facilitate endosomal escape of nonviral vectors and thereby improve transfection. PPAA markedly increased gene expression and transfection rates in NIH3T3 cells, improved serum stability of DOTAP/DNA vectors, and maintained high transfection levels in up to 50 % serum, indicating its potential for in vivo delivery of nucleic acids and proteins.
The efficient release of nonviral gene carriers from endosomes is an important step for the successful delivery of DNA into the cell nucleus. A synthetic pH-sensitive anionic polymer, poly(propylacrylic acid) (PPAA), was designed to aid in endosomal escape of nonviral vectors and improve the transfection efficiencies with these vectors. Transfection of NIH3T3 fibroblasts with ternary physical mixtures of the cationic lipid DOTAP, pCMVβ plasmid DNA, and PPAA showed marked enhancement of both gene expression levels and fraction of cells transfected compared to binary control mixtures of DOTAP and DNA. PPAA also significantly improved the serum-stability of DOTAP/DNA vectors. The DOTAP/DNA/PPAA vectors maintained high levels of transfection in media containing up to 50% serum. The striking enhancement of transfection efficiency with cationic lipid/DNA/PPAA mixtures, along with the enhanced serum-stability, suggests that PPAA may provide significant improvements for the in vivo intracellular delivery of drugs such as DNA, oligonucleotides, proteins, and peptides.
13
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
Marina Cavazzana, Salima Hacein‐Bey, Geneviève de Saint Basile et al. · Science · 2000 · 2.6K citations
Life Sciences, Genetics, Immunology +17
Cellular and Molecular Barriers to Gene Transfer by a Cationic Lipid
Joseph Zabner, A Fasbender, Tom Moninger et al. · Journal of Biological Chemistry · 1995 · 1.4K citations · Full text
Stabilized plasmid-lipid particles: construction and characterization
J J Wheeler, Lorne Palmer, M. Ossanlou et al. · Gene Therapy · 1999 · 302 citations